Leveraging the discovery of transglutaminase-mediated immunodominance (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023021335), Tree of Life Biologics INC. provides novel and proprietary artificial intelligence-powered epitope mapping and immunogen design services and products for the development of vaccines and peptides ai
Leveraging the discovery of transglutaminase-mediated immunodominance (https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023021335), Tree of Life Biologics INC. provides novel and proprietary artificial intelligence-powered epitope mapping and immunogen design services and products for the development of vaccines and peptides aiming to prevent and treat most life-threatening diseases today.
We perform cost-efficient epitope identification algorithms and immunogen screening campaigns to determine the immunodominant epitopes and their variants in any target protein of any disease.
Our platform for immunogen determination and optimization is a technology evolving epitope design. First, the epitope candidates would induce both humoral and T cell responses memorized by the body. Second, our approach could optimize the epitope motif into a more immunoreactive variant. Third, introduction of glutamine residues is able to create immunogenicity for a peptide.